• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为未筛选的肝移植受者使用高龄供体的实际风险:欧洲单中心在终末期肝病模型(MELD)时代的经验

Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era.

作者信息

Bertuzzo Valentina Rosa, Cescon Matteo, Odaldi Federica, Di Laudo Marco, Cucchetti Alessandro, Ravaioli Matteo, Del Gaudio Massimo, Ercolani Giorgio, D'Errico Antonietta, Pinna Antonio Daniele

机构信息

*Department of Medical and Surgical Sciences, General and Transplant Surgery Unit, S. Orsola-Malpighi Hospital, Alma Mater Studiorum, University of Bologna, Bologna, Italy †Department of Medical and Surgical Sciences, Pathology Unit, S. Orsola-Malpighi Hospital, Alma Mater Studiorum, University of Bologna, Bologna, Italy.

出版信息

Ann Surg. 2017 Feb;265(2):388-396. doi: 10.1097/SLA.0000000000001681.

DOI:10.1097/SLA.0000000000001681
PMID:28059967
Abstract

OBJECTIVE

To evaluate the whole experience of liver transplantation (LT) with donors ≥70 years in a single center not applying specific donor/recipient matching criteria.

BACKGROUND

LT with very old donors has historically been associated with poorer outcomes. With the increasing average donor age and the advent of Model for End-stage Liver Diseases (MELD) score-based allocation criteria, an optimal donor/recipient matching is often unsuitable.

METHODS

Outcomes of all types of LTs were compared according to 4 study groups: patients transplanted between 1998 and 2003 with donors <70 (group 1, n = 396) or ≥70 years (group 2, n = 88); patients transplanted between 2004 and 2010 with donors <70 (group 3, n = 409), or ≥70 years (group 4, n = 190). From 2003, graft histology was routinely available before cross-clamping, and MELD-driven allocation was adopted.

RESULTS

Groups 1 and 2 were similar for main donor and recipient variables, and surgical details. Group 4 had shorter donor ICU stay, lower rate of moderate-to-severe graft macrosteatosis (2.3% vs 8%), and higher recipient MELD score (22 vs 19) versus group 3. After 2003, median donor age, recipient age, and MELD score significantly increased, whereas moderate-to-severe macrosteatosis and ischemia time decreased. Five-year graft survival was 63.6% in group 1 versus 59.1% in group 2 (P = 0.252) and 70.9% in group 3 versus 67.6% in group 4 (P = 0.129). Transplants performed between 1998 and 2003, recipient HCV infection, balance of risk score >18, and pre-LT renal replacement treatments were independently associated with worse graft survival.

CONCLUSIONS

Even without specific donor/recipient matching criteria, the outcomes of LT with donors ≥70 and <70 years are comparable with appropriate donor management.

摘要

目的

在一个未应用特定供体/受体匹配标准的单一中心,评估使用70岁及以上供体进行肝移植(LT)的整体情况。

背景

使用高龄供体进行肝移植在历史上一直与较差的预后相关。随着供体平均年龄的增加以及基于终末期肝病模型(MELD)评分的分配标准的出现,最佳的供体/受体匹配往往并不适用。

方法

根据4个研究组比较了所有类型肝移植的结果:1998年至2003年间接受移植的患者,供体年龄<70岁(第1组,n = 396)或≥70岁(第2组,n = 88);2004年至2010年间接受移植的患者,供体年龄<70岁(第3组,n = 409)或≥70岁(第4组,n = 190)。从2003年起,在夹闭血管前常规获取移植物组织学检查结果,并采用基于MELD评分的分配方式。

结果

第1组和第2组在主要供体和受体变量以及手术细节方面相似。与第3组相比,第4组供体在重症监护病房的停留时间更短,中重度移植物大脂肪变发生率更低(2.3%对8%),受体MELD评分更高(22对19)。2003年后,供体年龄中位数、受体年龄和MELD评分显著增加,而中重度大脂肪变和缺血时间减少。第1组的5年移植物存活率为63.6%,第2组为59.1%(P = 0.252);第3组为70.9%,第4组为67.6%(P = 0.129)。1998年至2003年间进行的移植、受体丙型肝炎病毒感染、风险评分平衡>18以及肝移植前的肾脏替代治疗与较差的移植物存活率独立相关。

结论

即使没有特定的供体/受体匹配标准,使用70岁及以上和70岁以下供体进行肝移植的结果在进行适当的供体管理时是可比的。

相似文献

1
Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era.为未筛选的肝移植受者使用高龄供体的实际风险:欧洲单中心在终末期肝病模型(MELD)时代的经验
Ann Surg. 2017 Feb;265(2):388-396. doi: 10.1097/SLA.0000000000001681.
2
Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.通过供体和受体特征的策略性匹配优化再次肝移植移植物的效用。
Liver Transpl. 2015 Nov;21(11):1365-73. doi: 10.1002/lt.24138.
3
Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation.终末期肝病供体模型及肝移植供受体匹配
Transplant Proc. 2011 May;43(4):974-6. doi: 10.1016/j.transproceed.2011.01.138.
4
Analyzing predictors of graft survival in patients undergoing liver transplantation with donors aged 70 years and over.分析 70 岁及以上供体肝移植患者移植物存活的预测因素。
World J Gastroenterol. 2018 Dec 21;24(47):5391-5402. doi: 10.3748/wjg.v24.i47.5391.
5
Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.在乙肝流行地区,对终末期肝病模型评分≥35的患者进行活体供肝与尸体供肝肝移植的短期和长期疗效比较
Ann Surg. 2017 Jan;265(1):173-177. doi: 10.1097/SLA.0000000000001671.
6
The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.30 年来肝移植的演变:单中心 5347 例连续肝移植分析。
Ann Surg. 2013 Sep;258(3):409-21. doi: 10.1097/SLA.0b013e3182a15db4.
7
Donor Age-Based Analysis of Liver Transplantation Outcomes: Short- and Long-Term Outcomes Are Similar Regardless of Donor Age.基于供体年龄的肝移植结果分析:无论供体年龄如何,短期和长期结果相似。
J Am Coll Surg. 2015 Jul;221(1):59-69. doi: 10.1016/j.jamcollsurg.2015.01.061. Epub 2015 Feb 28.
8
Effects of Donor Age and Cold Ischemia on Liver Transplantation Outcomes According to the Severity of Recipient Status.根据受体状态严重程度,供体年龄和冷缺血对肝移植结局的影响。
Dig Dis Sci. 2016 Feb;61(2):626-35. doi: 10.1007/s10620-015-3910-7.
9
Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.活体捐赠与循环死亡后肝脏移植在低终末期肝病模型受体中的比较。
Liver Transpl. 2019 Apr;25(4):580-587. doi: 10.1002/lt.25073. Epub 2019 Mar 6.
10
Liver Transplant Survival Index for Patients with Model for End-Stage Liver Disease Score ≥ 35: Modeling Risk and Adjusting Expectations in the Share 35 Era.终末期肝病模型评分≥35 的患者肝移植生存指数:在 Share 35 时代评估风险和调整预期。
J Am Coll Surg. 2019 Apr;228(4):437-450.e8. doi: 10.1016/j.jamcollsurg.2018.12.009. Epub 2018 Dec 27.

引用本文的文献

1
Liver Transplantation from Elderly Donors (≥85 Years Old).老年供体(≥85岁)的肝移植
Cancers (Basel). 2024 May 8;16(10):1803. doi: 10.3390/cancers16101803.
2
Machine Perfusion for Extended Criteria Donor Livers: What Challenges Remain?边缘供肝的机器灌注:仍存在哪些挑战?
J Clin Med. 2022 Sep 3;11(17):5218. doi: 10.3390/jcm11175218.
3
Targeting the Hepatic Microenvironment to Improve Ischemia/Reperfusion Injury: New Insights into the Immune and Metabolic Compartments.靶向肝脏微环境以改善缺血/再灌注损伤:免疫和代谢区室的新见解
Aging Dis. 2022 Jul 11;13(4):1196-1214. doi: 10.14336/AD.2022.0109.
4
How Old Is Old? An Age-Stratified Analysis of Elderly Liver Donors above 65.多大算老龄?65岁以上老年肝供体的年龄分层分析。
J Clin Med. 2022 Jul 4;11(13):3899. doi: 10.3390/jcm11133899.
5
A Novel Preservation Solution Containing Quercetin and Sucrose for Porcine Kidney Transplantation.一种含槲皮素和蔗糖的新型猪肾移植保存液
Transplant Direct. 2020 Nov 10;6(12):e624. doi: 10.1097/TXD.0000000000001077. eCollection 2020 Dec.
6
Ischemia-Reperfusion Injury in Marginal Liver Grafts and the Role of Hypothermic Machine Perfusion: Molecular Mechanisms and Clinical Implications.边缘性肝移植中的缺血再灌注损伤及低温机器灌注的作用:分子机制与临床意义
J Clin Med. 2020 Mar 20;9(3):846. doi: 10.3390/jcm9030846.
7
Irisin Improves Autophagy of Aged Hepatocytes via Increasing Telomerase Activity in Liver Injury.鸢尾素通过增加肝损伤中端粒酶活性改善衰老肝细胞的自噬。
Oxid Med Cell Longev. 2020 Jan 2;2020:6946037. doi: 10.1155/2020/6946037. eCollection 2020.
8
Machine perfusion strategies in liver transplantation.肝移植中的机器灌注策略
Hepatobiliary Surg Nutr. 2019 Oct;8(5):490-501. doi: 10.21037/hbsn.2019.04.04.
9
Mild hypothermia during the reperfusion phase protects mitochondrial bioenergetics against ischemia-reperfusion injury in an animal model of ex-vivo liver transplantation-an experimental study.复灌期轻度低体温对离体肝移植动物模型缺血再灌注损伤中线粒体生物能量学的保护作用:一项实验研究。
Int J Med Sci. 2019 Sep 7;16(9):1304-1312. doi: 10.7150/ijms.34617. eCollection 2019.
10
Systematic Evaluation of the Safety Threshold for Allograft Macrovesicular Steatosis in Cadaveric Liver Transplantation.尸体肝移植中同种异体大泡性脂肪变性安全阈值的系统评价
Front Physiol. 2019 Apr 25;10:429. doi: 10.3389/fphys.2019.00429. eCollection 2019.